A phase I/II multicentric Belgian prospective novel sequential chemo-immunotherapy regimen for adjuvant treatment in non-muscle invasive bladder cancer.
Phase of Trial: Phase I/II
Latest Information Update: 22 Mar 2012
At a glance
- Drugs BCG (Primary) ; Mitomycin (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 03 Mar 2012 Planned end date changed from 11 Feb 2013 to 1 Sep 2013 as reported by as reported by European Clinical Trials Database.
- 03 Mar 2012 Actual initiation date changed from 11 Feb 2011 to 4 Mar 2011 as reported by as reported by European Clinical Trials Database.
- 23 May 2011 New trial record